Independent and P2S supine breast MRI tumor contrast compared to prone MRI in surgical guidance.
Supine breast MRI matches prone for tumor contrast in surgery planning
This cohort study evaluated subjects undergoing breast MRI for surgical guidance comparing independent supine and P2S supine imaging against…
A new study finds supine breast MRI can match prone imaging for tumor contrast, potentially improving surgical guidance.
Absence of antiviral therapy and multiple chemotherapeutic agents increase HBV reactivation risk after TACE
No Antiviral Meds Raise Liver Cancer Risks After Chemo
This retrospective cohort study of 168 HBsAg-positive HCC patients undergoing TACE found that absence of prophylactic antiviral therapy (OR …
Many liver cancer patients with hepatitis B face avoidable risks during chemo—because they’re not getting a simple antiviral pill most alrea…
NTCP Models Underestimate Radiation Pneumonitis Risk in Lung Cancer Patients
New tool better predicts lung damage from radiation therapy
This cohort study of 580 lung cancer patients found that QUANTEC and Appelt NTCP models systematically underestimated radiation pneumonitis …
A new risk model more accurately predicts lung injury after modern radiation therapy for lung cancer, helping doctors tailor safer treatment…
Modified thin-slab volume rendering improves diagnostic performance for pneumonic-type lung cancer and inflammatory pneumonia.
New Imaging Trick Tells Cancer and Pneumonia Apart
This retrospective cohort study evaluated modified thin-slab volume rendering (tsVR) with densitometry-derived thresholds against convention…
Doctors can now tell aggressive lung cancer apart from pneumonia more accurately using a simple tweak to CT scans that highlights subtle dif…
Deep Learning MRI Models Predict Treatment Response in Hepatocellular Carcinoma Following Transarterial Chemoembolization
AI Models Predict Liver Cancer Treatment Response Better Than Standard Scores
This cohort study evaluated AI models using gadoxetic acid–enhanced MRI in 160 patients with Barcelona Clinic Liver Cancer stage A or B hepa…
Artificial intelligence using MRI scans predicted how patients with liver cancer would respond to treatment more accurately than standard cl…
Adjuvant chemotherapy improves overall survival in resectable stage I-III duodenal adenocarcinoma patients.
After Surgery, This Extra Step May Extend Survival in Rare Cancer
This retrospective cohort study evaluated 98 patients with resectable stage I-III duodenal adenocarcinoma at two Chinese institutions. Patie…
After surgery for duodenal cancer, adding chemotherapy may nearly double survival time, but larger trials are still needed.
Systematic review and meta-analysis of robotic versus laparoscopic surgery for rectal cancer
Robotic surgery shows lower urinary retention for rectal cancer patients in a review of 6,121 cases.
This systematic review and meta-analysis evaluated robotic versus laparoscopic surgery in 6121 rectal cancer patients with 12.0 months of fo…
A review of 6,121 rectal cancer patients found robotic surgery led to less urinary retention than laparoscopic surgery, though other functio…
Systematic review and meta-analysis compares subcutaneous versus intravenous PD-1/PD-L1 inhibitors for solid tumors.
Subcutaneous shots match intravenous drugs for cancer survival and response rates in solid tumors.
This systematic review and meta-analysis of 1243 patients with solid tumors found no significant difference in overall survival, progression…
A large review found that giving cancer drugs under the skin works just as well as the traditional vein injection for patients with solid tu…
Specialized palliative care intervention enrollment patterns in a glioblastoma randomized controlled trial sub-analysis
Glioblastoma trial reveals why patients skip or delay visits
This sub-analysis of the Early Palliative Care for Patients with Glioblastoma (EPCOG) trial examined enrollment and retention among 556 scre…
Many glioblastoma patients skip or delay study visits due to illness or lack of interest, a new trial analysis finds.
Abexinostat showed a 69.5% objective response rate in relapsed follicular lymphoma patients.
New Drug Shrinks Stubborn Lymphoma Tumors After Other Treatments Fail
This single-arm, multi-center phase 2 study evaluated abexinostat in 90 patients with relapsed or refractory follicular lymphoma who had rec…
A new treatment is helping some patients with stubborn lymphoma shrink tumors and stay in control for over a year, even after other therapie…
Narrative review suggests multi-omics AI models improve glioma radiotherapy response prediction over single-modality approaches.
Glioma Radiotherapy Gets Smarter With Biomarker-Guided Dosing
This narrative review synthesizes evidence regarding multi-omics artificial intelligence models for predicting radiotherapy response in glio…
New biomarkers may help doctors tailor radiation doses for glioma patients, improving outcomes and reducing side effects.
Taxane-Based and Long-Course Chemotherapy Linked to Higher Breast Cancer-Related Lymphedema Risk
New Data Links Chemo Drugs to Arm Swelling in Breast Cancer
In a retrospective cohort of 201 breast cancer patients at Guangzhou Red Cross Hospital, taxane-based regimens, long-course chemotherapy, an…
Breast cancer patients on certain chemotherapy drugs face a higher risk of developing arm swelling after treatment ends.